NCT02647619View on ClinicalTrials.gov

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Dupuytren Contracture
Interventions
DRUG

Xiapex

Injection of collagenase of primary dupytren cord

PROCEDURE

Needle aponeurotomy

26 G needle multiple perforation tecqnique with local anesthetic

Trial Locations (1)

1478

Akershus University Hospital, Oslo

All Listed Sponsors
lead

University Hospital, Akershus

OTHER

NCT02647619 - Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF | Biotech Hunter | Biotech Hunter